Related references
Note: Only part of the references are listed.Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu et al.
CELL DISCOVERY (2020)
O39 Implementing screening for hydroxychloroquine ocular toxicity: how big is the problem? Epidemiology of hydroxychloroquine prescriptions in the UK Clinical Practice Research Datalink
Fiona A Pearce et al.
RHEUMATOLOGY (2019)
Hydroxychloroquine use: the potential impact of new ocular screening guidelines
M. Yates et al.
EYE (2018)
The effect of hydroxychloroquine on haemostasis, complement, inflammation and angiogenesis in patients with antiphospholipid antibodies
Karen Schreiber et al.
RHEUMATOLOGY (2018)
New use for an old treatment: Hydroxychloroquine as a potential treatment for systemic vasculitis
Alina Casian et al.
AUTOIMMUNITY REVIEWS (2018)
HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: A Multinational Randomized Controlled Trial of Hydroxychloroquine versus Placebo in Addition to Standard Treatment in Pregnant Women with Antiphospholipid Syndrome or Antibodies
Karen Schreiber et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2017)
Hydroxychloroquine-related retinal toxicity
Hui Jen Ding et al.
RHEUMATOLOGY (2016)
The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies
S. Sciascia et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2016)
The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective study
Arsene Mekinian et al.
AUTOIMMUNITY REVIEWS (2015)
Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study
Yi-Ming Chen et al.
RHEUMATOLOGY (2015)
Serious Infections Among Adult Medicaid Beneficiaries With Systemic Lupus Erythematosus and Lupus Nephritis
Candace H. Feldman et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Hydroxychloroquine: A multifaceted treatment in lupus
Nathalie Costedoat-Chalumeau et al.
PRESSE MEDICALE (2014)
The Risk of Toxic Retinopathy in Patients on Long-term Hydroxychloroquine Therapy
Ronald B. Melles et al.
JAMA OPHTHALMOLOGY (2014)
Chloroquine and hydroxychloroquine for cancer therapy
Gwenola Manic et al.
MOLECULAR & CELLULAR ONCOLOGY (2014)
Hydroxychloroquine: From Malaria to Autoimmunity
Ilan Ben-Zvi et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2012)
Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects
C. Tang et al.
INTERNAL MEDICINE JOURNAL (2012)
Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect
E. Cairoli et al.
LUPUS (2012)
Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells
Rayhana Rahim et al.
ANTI-CANCER DRUGS (2009)
Previous antimalarial therapy in patients diagnosed with lupus nephiritis: Influence on outcomes and survival
A. Siso et al.
LUPUS (2008)
Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century
Jean-Marc Rolain et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus:: Data from LUMINA, a multiethnic US cohort (LUMINA L)
Graciela S. Alarcon et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Different effects of chloroquine and hydroxychloroquine on lysosomal function in cultured retinal pigment epithelial cells
SP Sundelin et al.
APMIS (2002)
Vascular stiffness in women with systemic lupus erythematosus
F Selzer et al.
HYPERTENSION (2001)
Share Paper
